Misfolded polyglutamine, polyalanine, and superoxide dismutase 1 aggregate via distinct pathways in the cell

J Biol Chem. 2014 Mar 7;289(10):6669-6680. doi: 10.1074/jbc.M113.520189. Epub 2014 Jan 14.

Abstract

Protein aggregation into intracellular inclusions is a key feature of many neurodegenerative disorders. A common theme has emerged that inappropriate self-aggregation of misfolded or mutant polypeptide sequences is detrimental to cell health. Yet protein quality control mechanisms may also deliberately cluster them together into distinct inclusion subtypes, including the insoluble protein deposit (IPOD) and the juxtanuclear quality control (JUNQ). Here we investigated how the intrinsic oligomeric state of three model systems of disease-relevant mutant protein and peptide sequences relates to the IPOD and JUNQ patterns of aggregation using sedimentation velocity analysis. Two of the models (polyalanine (37A) and superoxide dismutase 1 (SOD1) mutants A4V and G85R) accumulated into the same JUNQ-like inclusion whereas the other, polyglutamine (72Q), formed spatially distinct IPOD-like inclusions. Using flow cytometry pulse shape analysis (PulSA) to separate cells with inclusions from those without revealed the SOD1 mutants and 37A to have abruptly altered oligomeric states with respect to the nonaggregating forms, regardless of whether cells had inclusions or not, whereas 72Q was almost exclusively monomeric until inclusions formed. We propose that mutations leading to JUNQ inclusions induce a constitutively "misfolded" state exposing hydrophobic side chains that attract and ultimately overextend protein quality capacity, which leads to aggregation into JUNQ inclusions. Poly(Q) is not misfolded in this same sense due to universal polar side chains, but is highly prone to forming amyloid fibrils that we propose invoke a different engagement mechanism with quality control.

Keywords: Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease); Analytical Ultracentrifugation; Flow Cytometry; Inclusion; Polyalanine; Polyglutamine; Protein Aggregation; Superoxide Dismutase (SOD).

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Amyloid / chemistry
  • Humans
  • Inclusion Bodies / chemistry
  • Mutation
  • Neurodegenerative Diseases / genetics
  • Neurodegenerative Diseases / metabolism
  • Peptides / chemistry*
  • Peptides / genetics
  • Protein Folding*
  • Superoxide Dismutase / chemistry*
  • Superoxide Dismutase / genetics
  • Superoxide Dismutase-1

Substances

  • Amyloid
  • Peptides
  • SOD1 protein, human
  • polyalanine
  • polyglutamine
  • Superoxide Dismutase
  • Superoxide Dismutase-1